PAUL SAGAN

CIK 1035440 · President · last filed 2026-06-22

PAUL SAGAN is a President who has filed 165 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for OKTA, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$88.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $70.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$70.07M

Companies

7

Total Filings

165

Lifetime Open-Market Net

-$88.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OKTA Director $138.43 $0 2 2026-06-22
MRNA Director 312,730 $56.66 $17.72M $1.30M 12 2025-05-01
VMWARE LLC (VMW) Delisted Director 1,482 $142.48 $211.2K $0 12 2023-11-22
AKAM Director 464,479 $112.72 $52.35M -$88.19M 100 2019-05-17
IROBOT CORP (IRBT) Delisted Director 18,052 $0.47 $8.4K -$1.93M 24 2015-06-09
DOW JONES & CO INC (DJ) Delisted Director $0 2 2007-10-02
DIGITAS INC (DTAS) Delisted Director 0 $0 1 2007-01-25

Recent Filings

165 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 OKTA Grant (A) $0 EDGAR
2026-06-18 MRNA Notice (144) −25,770 -$1.66M EDGAR
2026-05-08 MRNA Notice (144) −36,759 -$2.00M EDGAR
2025-12-22 OKTA Grant (A) $0 EDGAR
2025-05-01 MRNA Grant (A) $0 EDGAR
2025-03-04 MRNA Buy (P) +31,620 $1.00M EDGAR
2024-05-07 MRNA Grant (A) $0 EDGAR
2023-11-22 VMWARE LLC (VMW) Delisted Disp (D) −24,393 $0 EDGAR
2023-07-14 VMWARE LLC (VMW) Delisted Grant (A) +1,976 $0 EDGAR
2023-05-05 MRNA Grant (A) $0 EDGAR
Showing 110 of 165
Page 1 of 17
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.